Development

Articles

As technology advances, industry's needs are growing.

Ideas Know No Borders

The authors demonstrated that ODTs can be obtained by direct compression of a mixture of starch, fructose, and SMCC.

Orally Disintegrating Tablets Using Starch and Fructose

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Post recession and beyond, which contract service providers will still be standing?

Outsourcing Winners in 2014

Ranga Velagaleti is the manager of laboratory and stability at BASF Corporation, 8800 Line Ave., Shreveport, LA 71106, tel. 318.861.8040, fax 318.861.8004, velagar1@basf-corp.com

The authors present an update to the Wyeth/BASF experience with the IPEC Novel Excipient Safety Evaluation Procedure.

Solutol HS15 as a Novel Excipient

Stuart Needleman, president of active-ingredient development and manufacturing at Aptuit, discusses industry trends and challenges.

Q&A with Stuart Needleman, Aptuit

PPD and Bend Research Form Collaboration; Ricerca Makes Senior Appointment; And More.

Week of Oct. 25, 2010: Company and People Notes: PPD and Bend Research Form Collaboration; Ricerca Makes Senior Appointment; And More.

Pfizer Forms Pact with Biocon; Baxter Makes Appointments; And More.

Week of Oct. 18, 2010: Company and People Notes: Pfizer Forms Pact with Biocon; Baxter Makes Appointments; And More.

sanofi to Cut 25% of US Workforce; AMRI Names VP of Chemical Development; And More.

Company and People Notes: Week of Oct. 11, 2010: sanofi to Cut 25% of US Workforce; AMRI Names VP of Chemical Development; And More.

Company and People Notes: Novartis Settles with US Attorney's Office; Hospira Names VP, And More.

Week of Oct. 4, 2010: Company and People Notes: Novartis Settles with US Attorney's Office; Hospira Names VP, And More.

Michelle Hoffman, editorial director of Pharmaceutical Technology.

The reopened debate over embryonic-stem-cell research could stifle many other scientific pursuits.

Ingredients